News Category Search | MedStar Health

Featured News

  • Lucy De La Cruz
    January 20, 2022

    The renowned 39-year-old breast surgeon becomes youngest Latina woman to lead breast surgery program in U.S. at major academic medical center

    WASHINGTONLucy Maria De La Cruz, MD, has joined MedStar Georgetown University Hospital as chief of its Breast Surgery Program and director of the Betty Lou Ourisman Breast Health Center. Dr. De La Cruz is a fellowship-trained breast surgeon who specializes in advanced breast surgery procedures, including wireless lumpectomies, hidden scar technique, oncoplastic breast conservation, and nipple-sparing mastectomy. She has been published in more than two dozen peer-reviewed scientific journals, and her pivotal papers on nipple-sparing mastectomy and oncologic outcomes have been cited worldwide. She will also direct the hospital’s breast surgery fellowship program.

    Lucy De La Cruz

    “I am honored and excited to lead the breast surgery program and the Betty Lou Ourisman Breast Health Center at MedStar Georgetown University Hospital,” said De La Cruz. “It has been my life-long dream to bring my passion for medicine, helping others and building a state-of-the-art breast surgery program to advance breast health. I look forward to working with our multidisciplinary team of breast health experts to compassionately care for, educate and empower my patients in their health journey.”

    Dr. De La Cruz is an academic breast surgeon who conducts outcomes-focused research, and among her special interests are the impact of genomic mapping to guide breast cancer treatment and male breast cancer treatment. Her work is guided by a long-standing commitment to promoting equity and efficacy in breast cancer care delivery, using the principles of value-based health care.
      
    “The Betty Lou Ourisman Breast Health Center and MedStar Georgetown University Hospital are thrilled to have Dr. De La Cruz lead the breast surgery program. Her commitment to patients, their journey, and their outcomes are unmatched; and her expertise in novel surgical techniques brings new and beneficial options to patients,” said David H. Song, MD, MBA, FACS, Physician Executive Director, Plastic & Reconstructive Surgery, MedStar Georgetown University Hospital, Professor and Chair Department of Plastic Surgery, and Interim Chair, Department of Surgery, Georgetown University School of Medicine.
     
    Dr. De La Cruz’s story

    Dr. De La Cruz, 39, started her journey towards becoming the youngest Latina woman to lead a breast cancer surgery program at a major academic medical center at young age. As the daughter of international physician researchers, she spent a lot of time in labs where her parents worked, sparking her passion for medicine and “making a difference in people’s lives.” She grew up in Cuba, Mozambique, Spain, and Miami.
     
    In college, she studied abroad in the Dominican Republic at the Universidad Central Del Este School of Medicine, where students were involved in patient care very early in their education and training. There, she completed her medical degree, founded an American Medical Student Association chapter and raised scholarship funds to help those who couldn’t afford tuition.

    After graduation, she was told becoming a surgeon would be nearly impossible as a foreign medical graduate and a female. Despite this, De La Cruz obtained research fellowships from the University of Miami and George Washington University in Washington, D.C. She continued her journey by obtaining a one-year residency internship at Jackson Memorial Hospital at the University of Miami, where she earned the Intern of the Year award and an AOA medical honor society membership for her dedication to medical student teaching. During her residency, she worked on an award-winning oncologic outcomes research project for nipple-sparing mastectomy that continues to be cited worldwide.
     
    That same year, Dr. De La Cruz started her breast surgery fellowship at the University of Pennsylvania. Following graduation, she worked in private practice for a year before returning to the University of Pennsylvania as a faculty member in the associate program director of the breast cancer surgery fellowship program.
     
    After relocating to Washington, D.C., to be close to her family, she founded the breast cancer fellowship program curriculum at the Inova Health System. Now at MedStar Georgetown University Hospital and The Betty Lou Ourisman Breast Health Center, she continues to teach residents and fellows, pursue research, and care for patients – the fulfillment of her lifelong dream. 

    About MedStar Georgetown University Hospital

    About the Betty Lou Ourisman Breast Health Center


Share this

MedStar Health makes the news

All News

  • January 20, 2018


    Washington, D.C., (November 20, 2018)
    —Researchers from MedStar Washington Hospital Center and MedStar Health Research Institute will begin an Investigational Device Exemption (IDE) trial on full- thickness burn wounds using Kerecis Omega3 Burn.

    The Kerecis fish-skin product is currently FDA cleared to treat second-degree burn wounds, which extend into some of the underlying skin layer. The purpose of the feasibility trial is to obtain FDA approval for a full clinical trial, which can lead to indications as a treatment for third-degree burn wounds, as well as for the fish-skin product to be used as a temporary cover for such wounds. Third- degree burns extend to all layers of the skin.

    Kerecis Omega3 Burn is intact fish skin, rich in naturally occurring Omega3 fatty acids. When grafted onto damaged human tissue, it recruits the body’s own cells and is rapidly converted into living tissue, which results in fast, high-quality wound healing.

    About the Feasibility Trial

    The MedStar Health/Kerecis feasibility trial will enroll a small number of patients. If results are favorable, a second larger trial will be undertaken to collect data for a regulatory submission for third- degree burns approval under the FDA’s Pre-Market Approval (PMA) regulatory mechanism.

    The study is part of a Kerecis program being sponsored by the U.S. Military Burn Research Program and the Office of Naval Research. The program consists of both preclinical and clinical phases. The preclinical phase, which was conducted in Iceland and at the U.S. Army Institute of Surgical Research (ISR), San Antonio, has demonstrated better healing outcomes compared to other burn products on the market.

    The MedStar Health/Kerecis trial is scheduled to start in November 2018 and run through 2019.


    About MedStar Health Research Institute

    The MedStar Health Research Institute is the research arm of MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region. MHRI provides scientific, administrative, and regulatory support for research programs throughout the MedStar Health system. MHRI’s expertise includes translational research into disease prevention, diagnosis, and treatment. These programs complement the key clinical services and teaching programs in the 10 MedStar hospitals and other MedStar entities. For more information, visit MedStarResearch.org.

    About MedStar Health

    MedStar Health is a not-for-profit health system dedicated to caring for people in Maryland and the Washington, D.C., region while advancing the practice of medicine through education, innovation, and research. MedStar’s 30,000 associates, 6,000 affiliated physicians, 10 hospitals, ambulatory care and urgent care centers, and the MedStar Health Research Institute are recognized regionally and nationally for excellence in medical care. As the medical education and clinical partner of Georgetown University, MedStar trains more than 1,100 medical residents annually. MedStar Health’s patient-first philosophy combines care, compassion, and clinical excellence with an emphasis on customer service. For more information, visit MedStarHealth.org.

    About Kerecis

    Kerecis is the creator, manufacturer and patent holder of fish-skin-based therapeutic products that speed up the healing of human wounds and repair tissue damage. The Kerecis wound-healing product is patented in the United States and multiple other countries. The products are available in the United States, Iceland, Germany, and several other European and Asian countries. In collaboration with the U.S. Department of Defense, Kerecis is adapting the product for use in battlefield conditions, where skin substitutes have traditionally not been used.

    The Kerecis technology was invented by the company’s founder and CEO, Fertram Sigurjonsson. The fish skin comes from wild cod, sustainably caught in pristine Icelandic waters. Production takes place in the Kerecis manufacturing facility in Iceland, which uses electric power generated from geothermal and hydroelectric energy. For more information, visit www.kerecis.com. Distributor inquiries are welcome.

    Kerecis is a trademark of Kerecis. All other company and product names are trademarks of their respective owners.

  • January 20, 2018
    MedStar St. Mary’s Hospital is currently treating one patient, a 14-year-old male, following a shooting at Great Mills High School in Lexington Park, Maryland.
  • January 18, 2018


    Columbia, MD (December 17, 2018) 
    —The Coverys Community Healthcare Foundation, Inc. (Foundation) put out a call to action and distributed a request for proposals for projects focused on improving diagnostic accuracy. The Foundation put aside $3 million in funding for approved projects. The Foundation received an overwhelming response to the request for proposals and MedStar Health’s proposal, titled “Improving diagnostic accuracy for Hepatitis C with a validated teach/improve model” was one of the 11 grant recipients selected for funding. Read more

  • January 18, 2018

    Hyattsville, MD (June 18, 2018)—A team of researchers from MedStar Health has been awarded an 18-month contract from the Agency for Healthcare Research and Quality (AHRQ) to support the development and testing of technical tools and apps that can be used to collect patient-reported outcome data. This federal contract was awarded through AHRQ’s ACTION III (Accelerating Change and Transformation in Organizations and Networks) funding mechanism. This is one of three contracts that have been awarded to MedStar Health as part of this federal contract vehicle.

    With the implementation of electronic health records and the growth of data available to physicians, increased efforts are being made to access more information directly from patients to help clinicians make informed care decisions. This includes the use of patient-reported outcome data, which are any reports of the status of a patient’s health condition that comes directly from the patient, without interpretation by a clinician.  Such patient information captures quality of life, ongoing symptoms, and daily activities, and can help guide clinicians in their care and treatment decisions. 

    “Ensuring that patients have a way to report on outcomes that are meaningful to them is critical to the delivery of safe and effective care. The growth of data science as part of clinical care is helping us at MedStar Health to turn this data into improved quality of life for our patients,” says Neil Weissman, MD, chief scientific officer for MedStar Health and president of MedStar Health Research Institute. “The ongoing collaboration through the ACTION III network will help to advance the health of patients beyond our care sites and community.”

    The team’s co-principal investigators are Deliya Wesley, PhD, MPH, and Kathryn M. Kellogg, MD, MPH, with Raj Ratwani, PhD, serving as the project director. Georgetown University and the CAPRICORN Practice-Based Research Network (PBRN) are collaborators on this project.

    MedStar Health will support the development and testing of two apps using specified health IT requirements and standards for use with electronic health records or other health information technology systems to collect patient-reported outcome data for clinical and research use.

    The team will work with key stakeholders to collect information on the usability and functional requirements for the apps designed to collect patient-reported outcome data on physical functioning. The apps will be pilot-tested and evaluated in 10 diverse primary and specialty care practices across MedStar Health and eight CAPRICORN primary care sites. The apps will be evaluated on the success of data collection and integration of these data within the electronic health record for clinical decisions, quality improvement, and research.

     


    About MedStar Health Research Institute

    The MedStar Health Research Institute is the research arm of MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region. MHRI provides scientific, administrative and regulatory support for research programs throughout the MedStar Health system. MHRI’s expertise includes translational research into disease prevention, diagnosis, and treatment. These programs complement the key clinical services and teaching programs in the 10 MedStar hospitals and other MedStar entities. For more information, visit www.MedStarResearch.org

    About MedStar Health
    MedStar Health is a not-for-profit health system dedicated to caring for people in Maryland and the Washington, D.C., region while advancing the practice of medicine through education, innovation, and research. MedStar’s 30,000 associates, 6,000 affiliated physicians, 10 hospitals, ambulatory care and urgent care centers, and the MedStar Health Research Institute are recognized regionally and nationally for excellence in medical care. As the medical education and clinical partner of Georgetown University, MedStar trains more than 1,100 medical residents annually. MedStar Health’s patient-first philosophy combines care, compassion and clinical excellence with an emphasis on customer service. For more information, visit MedStarHealth.org.

  • January 18, 2018

    Joan Bardsley, MBA, RN, CDE, FAADE, Assistant Vice President of Nursing and Clinical Integration for MedStar Health Research Institute (MHRI) and MedStar Corporate Nursing has been named Chair of The National Certification Board for Diabetes Educators (NCBDE) for 2018. The NCBDE promotes comprehensive diabetes education to support certified diabetes educators providing quality education and support. Read more.

  • January 17, 2018

    BALTIMORE—Young athletes and their parents will learn from top sports medicine experts and hear from a Baltimore Ravens player at the inaugural Playmore! Youth Sports Symposium, sponsored by MedStar Sports Medicine, Saturday, May 19.

    The event, which runs from 8:15 a.m. to 3 p.m., will include an educational symposium where sports medicine physicians will cover topics such as whether young athletes should specialize in one sport and how to keep young athletes safe. Children attending the event can participate in activities such as wiffle ball, soccer, flag football and running.

    The keynote speakers will be Morgan Cox, a long snapper for the Baltimore Ravens, who will speak at 12:30 p.m.; and Bryce Crawford, the assistant men’s basketball coach for the University of Maryland, Baltimore County Retrievers, who will speak at 9:25 a.m.

    “Many children today are highly specialized in a singular sport and participating in competitive, organized team sports year-round,” said Lindsay Jones, MD, a pediatric sports medicine physician for MedStar Sports Medicine. “This shift calls for open discussion about injury prevention, and best practices-- how best to care for and develop these talented young athletes.”

    Event details:

    Saturday, May 19th, 2018 | 8:15am – 3:00pm | M&T Bank Stadium

    Cost: $35 (includes 1 child, additional kids $15 each)

    Lunch provided. Space is limited.

    RSVP at MedStarSportsMed.org/PlayMore

    #

    About MedStar Health

    MedStar Health is a not-for-profit health system dedicated to caring for people in Maryland and the Washington, D.C., region, while advancing the practice of medicine through education, innovation and research. MedStar’s 30,000 associates, 6,000 affiliated physicians, 10 hospitals, ambulatory care and urgent care centers, and the MedStar Health Research Institute are recognized regionally and nationally for excellence in medical care. As the medical education and clinical partner of Georgetown University, MedStar trains more than 1,100 medical residents annually. MedStar Health’s patient-first philosophy combines care, compassion and clinical excellence with an emphasis on customer service. For more information, visit MedStarHealth.org.

    About MedStar Sports Medicine

    MedStar Sports Medicine is one of the premier sports medicine programs in the country. Over the past 30 years, MedStar Sports Medicine has grown to include more than 60 physicians, 40 certified athletic trainers and a network of therapists, nutritionists, and support staff at MedStar Health’s ten hospitals and diversified services. Focused on patient care, education, research and team relationships, this network of medical professionals is dedicated to enhancing the health and performance of all active people. More than 40 sports organizations, including the Baltimore Ravens, Baltimore Orioles, Washington Capitals, Washington Wizards, and US Lacrosse, have chosen MedStar Sports Medicine as their official sports medicine team. Visit us at MedStarSportsMed.org, or call 888-44-SPORT (888-447-7678).